Efficacy of Sambucol in the Treatment of Influenza
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The trial will examine the efficacy of sambucol in the treatment of influenza. The primary
efficacy endpoint will be the length of time to resolution of influenza illness.The double
blind trial will be conducted at the Personnel Clinic, and at the Clinical virology Unit,
Hadassah University Hospital, and will include 100 patients with laboratory-confirmed
influenza infection, 50 in the sambucol and 50 in the placebo study arm.